DNase armored CAR T cell therapies -（Xenetic Biosciences）

N/A

Report date: 2022/08/11 10:45:07

Base Information

Drug NameDNase armored CAR T cell therapies -（Xenetic Biosciences）
Drug Alias NameDNase armored CAR T cell therapies - Xenetic Biosciences/CLS TherapeuticsDNase armored CAR T cellDNase armored CAR T cell therapy
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXenetic Biosciences IncCls Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesXenetic Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A